Menu
Washingtoner
  • Home
  • Financial
  • Home
  • Business
  • Technology
  • Education
  • Construction
  • Services
  • Marketing
Washingtoner

Stuart Therapeutics, Inc. Announces Upcoming Presentations at ARVO 2024
Washingtoner/10255123

Trending...
  • Spokane: Council to Hold Press Conference to Discuss Further Information on Department of Justice Grant
  • TBM Council Appoints U.S. Department of Transportation CDIO Pavan Pidugu to Board of Directors
  • Tacoma Police Arrest Suspect in Series of Robberies Targeting Elderly Women
STUART, Fla., April 19, 2024 ~ Stuart Therapeutics, Inc., a clinical-stage ophthalmic biopharmaceutical company, is making strides in the development of therapies for various eye disorders. The company's President and CEO, Eric Schlumpf, will be presenting their latest research results at two upcoming meetings in early May.

On Friday, May 3rd, Schlumpf will be speaking at the Dry Horizons Symposium, co-sponsored by Ora, Inc. His presentation will focus on Stuart Therapeutics' innovative dry eye disease program, which is currently in a Phase 3 trial. The following day, Saturday May 4th, he will be presenting the company's latest pre-clinical results in retinitis pigmentosa and exudative retinal indications at the Ophthalmology Innovation Source (OIS) Retina Meeting.

Both of these meetings will take place at the Four Seasons Hotel in Seattle, Washington. This provides an opportunity for Stuart Therapeutics to showcase their groundbreaking research to a wide audience of industry professionals.

More on Washingtoner
  • STS Capital Partners' Andy Harris Co-Authors 'The Extraordinary Exit,' A Practical Guide for Business Owners Considering a Sale
  • One-Click Pro Audio for Streamers: "VoiceSterize" Automates Noise Reduction & Mastering on Mac
  • Sole Publishing Announces Essential Parenting Book for Families Navigating the Teen Years
  • From Factory Floor to Community Heart: The Rebel Spirit of Wisconsin's Wet Wipe Innovators
  • UK Financial Ltd Lists MayaFund (MFUND) ERC-20 Token on CATEX Exchange Ahead of Planned ERC-3643 Upgrade

In addition to Schlumpf's presentations, members of Stuart Therapeutics' R&D team have also co-authored a poster presentation that will be presented by researchers from the University of Rochester at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting from May 5-9, 2024. The poster presentation titled "Scleral collagen remodeling and repair assessed in intact eyes through Second Harmonic Generation" focuses on work done at the University of Rochester using Stuart Therapeutics' proprietary collagen mimetic peptide platform. This research aims to understand its effectiveness in reversing scleral collagen disruption in the eye, which is believed to contribute to myopia.

The study authors include Aldo Tecse, Kaitlin Wozniak, James German, Alex McMullen, Mark Buckley, Robert Baratta, Eric Schlumpf, Brian J. Del Buono, Michael Telias and Susana Marcos. This collaboration between Stuart Therapeutics and the University of Rochester highlights the company's commitment to advancing the field of ophthalmology and finding new treatments for eye disorders.

Stuart Therapeutics' presence at these upcoming meetings demonstrates their dedication to innovation and their potential to make a significant impact in the field of ophthalmology. With their cutting-edge research and promising results, they are poised to become a leader in developing therapies for anterior segment, refractive, and posterior segment eye disorders.
Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Spokane: Standoff With Domestic Violence Suspect Resolves Peacefully
  • Velixo Unveils Velixo Intelligence, Its New AI-Powered Assistants, at Acumatica Summit
  • GlobalBoost Media Advances Uncensorable Web on Blockchain with New Exchange Listings
  • Buildout Launches Native Email Marketing Feature, Expanding Its End-to-End CRE Platform
  • New Saxophone Prize Honors Astronaut Ronald E. McNair, First To Play Sax In Space
  • Building a $145M AI-Powered Marine Platform as Listings Surge, Global Expansion Begins, OTH Shares Trade at a Discount: Off The Hook YS (N Y S E: OTH)
  • American Disabilities Act Must Protect Against Forced Psychiatric Commitment and Treatment
  • 2025 Top Lawyers - ELA Awards by Expert Law Attorneys
  • Top Law Firms In 2025 - Expert Law Attorneys
  • Best Personal Injury Attorneys Of 2025 - ELA Awards
  • Best Personal Injury Law Firms 2025 - ELA Awards
  • Baruch Arcade Launches AI-Powered Gaming Platform on Solana, do I smell an airdrop?
  • Arux Group Launches WA Security Training Programs
  • Expert Law Attorneys 2025 Best Attorneys
  • Best Family Law Attorneys Of 2025 - ELA Awards
  • Best Criminal Defense Attorneys Of 2025 - ELA Awards
  • Americans Need $1.26 Million to Retire But Have Just $38K Saved — So They're Building Income Instead
  • Does EMDR Really Work? New Article Explores How Trauma Gets Stuck in the Brain and How Healing Begins
  • New Medium Article Explores Why Emotional Conversations Fail and What Most People Don't Understand About Connection
  • GlobalBoost Media (BSTY) Shows Bullish Signals: Technical Analysis and Exchange Updates
_catLbl0 _catLbl1

Popular on Washingtoner

  • City of Tacoma Secures Over $4 Million in Transportation Improvement Board Grants - 136
  • TBM Council Appoints Four Distinguished Leaders to Board of Directors - 110
  • Tacoma: Homicide Investigation – 3500 block of E Grandview Ave
  • Spokane: Council Members Official Swearing In Ceremony
  • AI-Driven Drug Development with Publication of New Bioinformatics Whitepaper for BullFrog AI: $BFRG Strengthens Its Position in AI Drug Development
  • Appliance EMT Expands Professional Appliance Repair Services to Hartford, Connecticut
  • Lacy Hendricks Earns Prestigious MPM® Designation from NARPM®
  • 2025: A Turning Point for Human Rights. CCHR Demands End to Coercive Psychiatry
  • Tacoma: Community Events on January 12 and January 15 Offer Opportunities to Meet Interim Police Chief Patti Jackson
  • CareerWork$® Appoints Latoya Edmond as Executive Director

Similar on Washingtoner

  • Precision Adult Care Expands 24/7 Adult In-Home Care Services to Meet Growing Demand in the Coachella Valley
  • Openchannelflow Wins Web Excellence Award for Outstanding Digital Experience
  • UK Financial Ltd Lists MayaFund (MFUND) ERC-20 Token on CATEX Exchange Ahead of Planned ERC-3643 Upgrade
  • Roblox and Solsten Alliances; a Stronger Balance Sheet and Accelerated Growth Through AI, Gaming, and Strategic Partnerships for Super League: $SLE
  • Scoop Social Co. Partners with Fairmont Hotels & Resorts to Elevate Summer Guest Experiences with Italian Inspired Gelato & Beverage Carts
  • Building a $145M AI-Powered Marine Platform as Listings Surge, Global Expansion Begins, OTH Shares Trade at a Discount: Off The Hook YS (N Y S E: OTH)
  • Americans Need $1.26 Million to Retire But Have Just $38K Saved — So They're Building Income Instead
  • Does EMDR Really Work? New Article Explores How Trauma Gets Stuck in the Brain and How Healing Begins
  • New Medium Article Explores Why Emotional Conversations Fail and What Most People Don't Understand About Connection
  • $80 Million Revenue Backlog for AI Cybersecurity Company Building the Future of Integrated Cybersecurity and Public Safety: $CYCU
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute